This title appears in the Scientific Report :
2022
Please use the identifier:
http://hdl.handle.net/2128/32143 in citations.
Please use the identifier: http://dx.doi.org/10.1007/s40263-022-00935-z in citations.
Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia
Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia
Saved in:
Personal Name(s): | Veselinović, Tanja (Corresponding author) |
---|---|
Neuner, Irene | |
Contributing Institute: |
Physik der Medizinischen Bildgebung; INM-4 |
Published in: | CNS drugs, 36 (2022) 8, S. 819 - 858 |
Imprint: |
Berlin [u.a.]
Springer
2022
|
DOI: |
10.1007/s40263-022-00935-z |
Document Type: |
Journal Article |
Research Program: |
Neuroimaging |
Link: |
OpenAccess |
Publikationsportal JuSER |
Please use the identifier: http://dx.doi.org/10.1007/s40263-022-00935-z in citations.
Description not available. |